Picture of Biocartis NV logo

BCART — Biocartis NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedMicro Cap

Brief: Biocartis Q1 Product Revenue Up At EUR 10.1 Mln

April 21 (Reuters) - BIOCARTIS GROUP NV  BCART.BR :
    * PRESS RELEASE BIOCARTIS GROUP NV: BIOCARTIS REPORTS
RESULTS OF
FIRST QUARTER OF 2022: ON TRACK TO DELIVER ON FULL-YEAR
GUIDANCE, GROSS MARGIN ON PRODUCTS OF 35%
    * Q1 GROSS MARGIN ON PRODUCT SALES OF 35%, COMPARED TO 16%
FOR
ENTIRE YEAR 2021
    * OPERATING CASH BURN OF EUR -10.3M AND CASH POSITION OF EUR
37.3M
(UNAUDITED FIGURE) END OF Q1 2022
    * Q1 PRODUCT REVENUE OF EUR 10.1M (Q1 2021: EUR 8.6M), OF
WHICH
EUR 8.1M REVENUE FROM 79.8K CARTRIDGES SOLD
    * RECONFIRMS ITS 2022 GUIDANCE TOWARDS DRIVING PROFITABLE
GROWTH

Source text for Eikon:  ID:nGNEScNB5 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))

Recent news on Biocartis NV

See all news